Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
27.21
-0.43 (-1.56%)
Jul 31, 2026, 4:00 PM EDT - Market closed
LKFT Market Cap
LKFT has a market cap or net worth of $1.81 billion as of July 31, 2026. Its market cap has decreased by -17.50% in one year.
Market Cap
1.81B
Enterprise Value
-1.61B
1-Year Change
-17.50%
Ranking
Category
Stock Price
$27.21
ChartMarket Cap Chart
Since May 14, 2015, LKFT's market cap has decreased from $1.86B to $1.81B, a decrease of -2.93%. That is a compound annual growth rate of -0.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.79B | -16.79% |
| Dec 31, 2025 | 2.15B | 18.91% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
| May 14, 2015 | 1.86B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 1.87B |
| UroGen Pharma | 1.86B |
| Kardigan | 1.86B |
| Fortrea Holdings | 1.82B |
| Iovance Biotherapeutics | 1.82B |
| Stoke Therapeutics | 1.80B |
| Generate Biomedicines | 1.79B |
| Agios Pharmaceuticals | 1.79B |